FDA outlines blood clot symptoms after J&J pause

U.S. federal health officials explained their decision to pause the use of Johnson & Johnson's COVID-19 vaccine during a virtual press briefing on Tuesday, saying six women under 50 who had received the single-dose shot developed rare blood clots.